Market closed
Bruker/$BRKR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Ticker
$BRKR
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
11,396
Website
Bruker Metrics
BasicAdvanced
$5.7B
49.72
$0.76
1.18
$0.20
0.53%
Price and volume
Market cap
$5.7B
Beta
1.18
52-week high
$84.90
52-week low
$34.10
Average daily volume
2.5M
Dividend rate
$0.20
Financial strength
Current ratio
1.602
Quick ratio
0.579
Long term debt to equity
120.136
Total debt to equity
123.694
Dividend payout ratio (TTM)
26.70%
Interest coverage (TTM)
20.63%
Management effectiveness
Return on assets (TTM)
5.10%
Return on equity (TTM)
7.05%
Valuation
Price to earnings (TTM)
49.719
Price to revenue (TTM)
1.67
Price to book
3.18
Price to tangible book (TTM)
-4.45
Price to free cash flow (TTM)
41.348
Dividend yield (TTM)
0.53%
Forward dividend yield
0.53%
Growth
Revenue change (TTM)
13.56%
Earnings per share change (TTM)
-73.83%
3-year revenue growth (CAGR)
11.66%
3-year earnings per share growth (CAGR)
-25.15%
3-year dividend per share growth (CAGR)
7.72%
What the Analysts think about Bruker
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Bruker stock.
Bruker Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Bruker Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Bruker News
AllArticlesVideos
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring
Business Wire·1 day ago
Bruker Announces First Quarter 2025 Preliminary Revenue
Business Wire·6 days ago
Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing
Business Wire·6 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bruker stock?
Bruker (BRKR) has a market cap of $5.7B as of April 17, 2025.
What is the P/E ratio for Bruker stock?
The price to earnings (P/E) ratio for Bruker (BRKR) stock is 49.72 as of April 17, 2025.
Does Bruker stock pay dividends?
Yes, the Bruker (BRKR) stock pays dividends to shareholders. As of April 17, 2025, the dividend rate is $0.2 and the yield is 0.53%. Bruker has a payout ratio of 26.7% on a trailing twelve-month basis.
When is the next Bruker dividend payment date?
The next Bruker (BRKR) dividend payment date is unconfirmed.
What is the beta indicator for Bruker?
Bruker (BRKR) has a beta rating of 1.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.